Zanubrutinib FDA approval date

The FDA approved Zanubrutinib (BRUKINSA®) on 14 Nov 2019.

FDA approval date
14 Nov 2019

Drug identity checked against registry records

Also recorded as BRUKINSA®

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2019-11-14DayZanubrutinibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA213217", "applicant_as_listed_by_fda": "BEONE MEDICINES USA", "brand_names": ["BRUKINSA"], "active_ingredients": ["ZANUBRUTINIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20191114", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026